XML 32 R21.htm IDEA: XBRL DOCUMENT v3.22.2
Stock-Based Compensation (Tables)
 6 Months Ended
Jun. 30, 2022
Share-based Payment Arrangement [Abstract]  
Schedule of Employee Service Share-based Compensation, Allocation of Recognized Period Costs Stock-based compensation expense is included on the Condensed Consolidated Statements of Income and Comprehensive Income based upon the job function of the employees receiving the grants as follows (in millions):
Three Months Ended
June 30,		Six Months Ended
June 30,
 2022202120222021
Lease and Well$10 $11 $23 $25 
Gathering and Processing Costs1 1 2 1 
Exploration Costs5 5 10 11 
General and Administrative14 14 30 29 
Total$30 $31 $65 $66 
Schedule of Weighted Average Fair Values and Valuation Assumptions
Weighted average fair values and valuation assumptions used to value stock option, SAR and ESPP grants during the six-month periods ended June 30, 2022 and 2021 are as follows:
 Stock Options/SARsESPP
Six Months Ended
June 30,		Six Months Ended
June 30,
 2022202120222021
Weighted Average Fair Value of Grants$28.30 $20.73 $23.07 $14.69 
Expected Volatility42.20 %46.40 %39.72 %54.99 %
Risk-Free Interest Rate0.89 %0.36 %0.22 %0.09 %
Dividend Yield3.28 %2.87 %3.32 %3.41 %
Expected Life5.3 years5.2 years0.5 years0.5 years
Schedule of Stock Options and SARs Transactions
The following table sets forth stock option and SAR transactions for the six-month periods ended June 30, 2022 and 2021 (stock options and SARs in thousands):
Six Months Ended
June 30, 2022		Six Months Ended
June 30, 2021
Number of
Stock
Options/SARs		Weighted
Average
Exercise
Price		Number of
Stock
Options/SARs		Weighted
Average
Exercise
Price
Outstanding at January 19,969 $84.37 10,186 $84.08 
Granted2 97.64 14 64.97 
Exercised (1)
(3,928)93.12 (239)69.85 
Forfeited(137)87.54 (234)91.54 
Outstanding at June 30 (2)
5,906 $78.49 9,727 $84.23 
Vested or Expected to Vest (3)
5,603 $79.15 9,421 $84.91 
Exercisable at June 30 (4)
2,305 $97.46 6,023 $97.08 
(1)The total intrinsic value of stock options/SARs exercised during the six months ended June 30, 2022 and 2021 was $108 million and $3 million, respectively. The intrinsic value is based upon the difference between the market price of EOG's common stock on the date of exercise and the exercise price of the stock options/SARs.
(2)The total intrinsic value of stock options/SARs outstanding at June 30, 2022 and 2021 was $202 million and $114 million, respectively. At June 30, 2022 and 2021, the weighted average remaining contractual life was 4.5 years and 3.8 years, respectively.
(3)The total intrinsic value of stock options/SARs vested or expected to vest at June 30, 2022 and 2021 was $189 million and $106 million, respectively. At June 30, 2022 and 2021, the weighted average remaining contractual life was 4.4 years and 3.8 years, respectively.
(4)The total intrinsic value of stock options/SARs exercisable at June 30, 2022 and 2021 was $44 million and $16 million, respectively. At June 30, 2022 and 2021, the weighted average remaining contractual life was 2.7 years.
Schedule of Restricted Stock and Restricted Stock Unit Transactions
The following table sets forth restricted stock and restricted stock unit transactions for the six-month periods ended June 30, 2022 and 2021 (shares and units in thousands):
Six Months Ended
June 30, 2022		Six Months Ended
June 30, 2021
Number of
Shares and
Units		Weighted
Average
Grant Date
Fair Value		Number of
Shares and
Units		Weighted
Average
Grant Date
Fair Value
Outstanding at January 14,680 $69.37 4,742 $74.97 
Granted48 115.48 45 72.56 
Released (1)
(780)91.98 (523)87.61 
Forfeited(85)66.23 (47)70.24 
Outstanding at June 30 (2)
3,863 $65.45 4,217 $73.43 
(1)The total intrinsic value of restricted stock and restricted stock units released during the six months ended June 30, 2022 and 2021 was $91 million and $38 million, respectively. The intrinsic value is based upon the closing price of EOG's common stock on the date the restricted stock and restricted stock units are released.
(2)The total intrinsic value of restricted stock and restricted stock units outstanding at June 30, 2022 and 2021 was $427 million and $352 million, respectively.
Schedule of Performance Award Transactions
The following table sets forth the Performance Unit transactions for the six-month periods ended June 30, 2022 and 2021 (units in thousands):
Six Months Ended
June 30, 2022		Six Months Ended
June 30, 2021
Number of
Units		Weighted
Average
Grant Date Fair Value		Number of
Units		Weighted
Average
Grant Date Fair Value
Outstanding at January 1679 $84.97 613 $88.38 
Granted— — 8 55.69 
Granted for Performance Multiple (1)
— — 19 113.81 
Released (2)
(57)136.74 (98)113.81 
Forfeited for Performance Multiple (3)
(56)136.74 — — 
Outstanding at June 30 (4)
566 (5)$74.60 542 $84.23 
(1)Upon completion of the Performance Period for the Performance Units granted in 2017, a performance multiple of 125% was applied to the grants resulting in an additional grant of Performance Units in February 2021.
(2)The total intrinsic value of Performance Units released was $7 million and $6 million for the six months ended June 30, 2022 and 2021, respectively. The intrinsic value is based upon the closing price of EOG's common stock on the date the Performance Units are released.
(3)Upon completion of the Performance Period for the Performance Units granted in 2018, a performance multiple of 50% was applied to the grants resulting in a forfeiture of Performance Units in February 2022.
(4)The total intrinsic value of Performance Units outstanding at June 30, 2022 and 2021 was approximately $62 million and $45 million, respectively.
(5)Upon the application of the relevant performance multiple at the completion of each of the remaining Performance Periods, a minimum of zero and a maximum of 1,132 Performance Units could be outstanding.